comparemela.com
Home
Live Updates
End Third Level - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - End third level - Page 1 : comparemela.com
China s NMPA accepts Legend Biotech s NDA for cilta-cel - Pharmaceutical Business review
Cilta-cel is a BCMA-directed and genetically modified autologous T-cell immunotherapy that involves reprogramming a patient’s own T-cells with a transgene encoding a chimeric antigen receptor (CAR), which detects
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
Vistagen agrees to acquire Pherin Pharmaceuticals
Vistagen has signed a definitive agreement for the acquisition of clinical-stage drug development firm Pherin Pharmaceuticals.
Shawn singh
Pherin pharmaceuticals
Robina weermeijer
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
FDA grants fast track designation for Kintara s breast cancer therapy
The US FDA has granted fast track designation (FTD) for Kintara Therapeutics’ REM-001, to treat cutaneous metastatic breast cancer (CMBC).
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
Everest regulatory updates in Taiwan, South Korea for Nefecon
The regulatory authorities in Taiwan and South Korea have granted fast-tracked approval process for Everest Medicines’ Nefecon.
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates
SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
vimarsana © 2020. All Rights Reserved.